Herr H - Search Results

1

Advanced seminoma: the role of chemotherapy and adjunctive surgery.

Motzer RJ, Bosl GJ, Geller NL, Penenberg D, Yagoda A, Golbey R, Whitmore WF Jr, Fair WR, Sogani P, Herr H, et al. Motzer RJ, et al. Among authors: herr h. Ann Intern Med. 1988 Apr;108(4):513-8. doi: 10.7326/0003-4819-108-4-513. Ann Intern Med. 1988. PMID: 2450500

2

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.

Motzer RJ, Gulati SC, Crown JP, Weisen S, Doherty M, Herr H, Fair W, Sheinfeld J, Sogani P, Russo P, et al. Motzer RJ, et al. Among authors: herr h. Cancer. 1992 Jan 15;69(2):550-6. doi: 10.1002/1097-0142(19920115)69:2<550::aid-cncr2820690245>3.0.co;2-d. Cancer. 1992. PMID: 1309436

3

Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.

Bajorin DF, Herr H, Motzer RJ, Bosl GJ. Bajorin DF, et al. Among authors: herr h. Semin Oncol. 1992 Apr;19(2):148-58. Semin Oncol. 1992. PMID: 1372757 Review.

4

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Pfister DG, Lin SY, Bajorin D, Scher HI, Herr H, Fair W, Morse M, et al. Motzer RJ, et al. Among authors: herr h. Cancer. 1990 Jun 1;65(11):2465-70. doi: 10.1002/1097-0142(19900601)65:11<2465::aid-cncr2820651112>3.0.co;2-7. Cancer. 1990. PMID: 1692505

5

Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Motzer RJ, Geller NL, Tan CC, Herr H, Morse M, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ. Motzer RJ, et al. Among authors: herr h. Cancer. 1991 Mar 1;67(5):1305-10. doi: 10.1002/1097-0142(19910301)67:5<1305::aid-cncr2820670506>3.0.co;2-j. Cancer. 1991. PMID: 1703917 Clinical Trial.

6

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P, et al. Motzer RJ, et al. Among authors: herr h. Cancer. 1990 Dec 15;66(12):2476-81. doi: 10.1002/1097-0142(19901215)66:12<2476::aid-cncr2820661206>3.0.co;2-d. Cancer. 1990. PMID: 2174300 Clinical Trial.

7

VAB-6 as initial treatment of patients with advanced seminoma.

Stanton GF, Bosl GJ, Whitmore WF Jr, Herr H, Sogani P, Morse M, Golbey RB. Stanton GF, et al. Among authors: herr h. J Clin Oncol. 1985 Mar;3(3):336-9. doi: 10.1200/JCO.1985.3.3.336. J Clin Oncol. 1985. PMID: 2579214

8

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Dershaw D, Reuter V, et al. Scher H, et al. Among authors: herr h. Br J Urol. 1989 Sep;64(3):250-6. doi: 10.1111/j.1464-410x.1989.tb06008.x. Br J Urol. 1989. PMID: 2804561

9

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.

Motzer RJ, Sheinfeld J, Mazumdar M, Bajorin DF, Bosl GJ, Herr H, Lyn P, Vlamis V. Motzer RJ, et al. Among authors: herr h. J Clin Oncol. 1995 Nov;13(11):2700-4. doi: 10.1200/JCO.1995.13.11.2700. J Clin Oncol. 1995. PMID: 7595727 Clinical Trial.

10

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.

Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P, et al. Bajorin DF, et al. Among authors: herr h. J Clin Oncol. 1993 Apr;11(4):598-606. doi: 10.1200/JCO.1993.11.4.598. J Clin Oncol. 1993. PMID: 8386751 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

824 results

Search Page

Filters